Nanomix

Nanomix is a company that is known for creating healthcare options for patients that can provide them with rapid and portable diagnostic systems. The company was founded in 2000 by Marvin L. Cohen and Alex Zettl, in Emeryville, California, United States.

The company offers their solutions in order to assist in the treatment and testing of COVID-19. The immunoassay approach Nanomix provides was designed to be handheld, provide rapid results with quantitative information, allowing for a mobile approach to testing diagnostics. Interactions between patients and healthcare professionals is possible at the hospital, via telecommunications, or through alternative point of care solutions with Nanomix.

Nanomix has developed their technologies in order to decentralize disease diagnostics. The assay diagnoses acute kidney injuries, SARS-CoV-2 antigens and antibody tests, cardiac issues, strokes, and traumatic brain injuries. Decentralizing the diagnosis process allows healthcare providers to offer direct and rapid information to their patients.